Fundraising Fox

Biotech Series B Investors & VC Firms

900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.

Perivoli Innovations
St. HelierPre-Seed–Growth
2 people
Starfish Ventures
MelbournePre-Seed–Growth$2M – $3.3M
2 people
LifeArc Ventures
LondonSeed–Growth
12 people
SIB Innovations- und Beteiligungsgesellschaft
DresdenSeed–Late Stage$54K – $10.8M
6 people
MDI Ventures
JakartaPre-Seed–Growth$500K – $75M
11 people
Expon Capital
LuxembourgPre-Seed–Series B$550K – $1.6M
4 people
Hikma Ventures
LondonSeed–Late Stage$5M
13 people
Tin Alley Ventures
MelbournePre-Seed–Late Stage
14 people
EUREKA! Venture
MilanSeed–Late Stage
4 people
SABIC Ventures
SittardSeed–Late Stage$500K – $20M
10 people
DCVC Bio
Palo AltoSeed–Growth
15 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage$1.9M – $227M
Blindspot Ventures Management Co
BostonPre-Seed–Late Stage
8 people
Excel Venture Management
BostonSeed–Late Stage$1M – $5M
8 people
Miyako Capital
KyotoPre-Seed–Growth
5 people
HM Venture Partners
San FranciscoSeed–Late Stage
7 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
15 people
BVCF
ShanghaiSeries A–Late Stage$5M
18 people
Highline Beta
TorontoPre-Seed–Growth
18 people
EIR Ventures
StockholmSeed–Growth
10 people
Seiho Investment Works
KyotoPre-Seed–Growth$67K – $670K
7 people
Cross-Border Impact Ventures
TorontoSeries A–Series B$2M – $10M
12 people
Domain Associates
PrincetonSeed–Growth$200K – $15M
11 people
Nordic Science Investments
HelsinkiPre-Seed–Series B$55K – $3.9M
8 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.